COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group
| dc.contributor.author | Panchawagh, Suhrud | |
| dc.contributor.author | Ravichandran, Naveen | |
| dc.contributor.author | Barman, Bhupen | |
| dc.contributor.author | Nune, Arvind | |
| dc.contributor.author | Javaid, Mahnoor | |
| dc.contributor.author | Gracia-Ramos, Abraham Edgar | |
| dc.contributor.author | Day, Jessica | |
| dc.contributor.author | Joshi, Mrudula | |
| dc.contributor.author | Kuwana, Masataka | |
| dc.contributor.author | Saha, Sreoshy | |
| dc.contributor.author | Pande, Arunkumar R. | |
| dc.contributor.author | Caballero-Uribe, Carlo Vinicio | |
| dc.contributor.author | Velikova, Tsvetelina | |
| dc.contributor.author | Parodis, Ioannis | |
| dc.contributor.author | Knitza, Johannes | |
| dc.contributor.author | Kadam, Esha | |
| dc.contributor.author | Tan, Ai Lyn | |
| dc.contributor.author | Shinjo, Samuel Katsuyuki | |
| dc.contributor.author | Boro, Hiya | |
| dc.contributor.author | Aggarwal, Rohit | |
| dc.contributor.author | Agarwal, Vikas | |
| dc.contributor.author | Chatterjee, Tulika | |
| dc.contributor.author | Gupta, Latika | |
| dc.contributor.author | Griger, Zoltán | |
| dc.contributor.author | Nagy-Vincze, Melinda | |
| dc.date.accessioned | 2024-01-15T09:11:49Z | |
| dc.date.available | 2024-01-15T09:11:49Z | |
| dc.date.issued | 2024 | |
| dc.date.oa | 2024-02-06 | |
| dc.date.pasync | 2025-05-25T23:08:32Z | |
| dc.date.updated | 2024-01-15T09:11:49Z | |
| dc.description.corrector | kzs | |
| dc.identifier.citation | Rheumatology International. -44 : 1 (2024), p. 73-80. -Rheumatol. Int. - 0172-8172. - 1437-160X | |
| dc.identifier.doi | http://dx.doi.org/10.1007/s00296-023-05496-y | |
| dc.identifier.issn | 1437-160X | |
| dc.identifier.issn | 0172-8172 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM117880 | |
| dc.identifier.scopus | 85181481512 | |
| dc.identifier.uri | https://hdl.handle.net/2437/365000 | |
| dc.identifier.url | https://link.springer.com/10.1007/s00296-023-05496-y | |
| dc.identifier.wos | 001116143800001 | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.rights.owner | szerző | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |